Somewhat Favorable Press Coverage Very Unlikely to Affect Cutera (CUTR) Share Price

Media coverage about Cutera (NASDAQ:CUTR) has trended somewhat positive recently, according to AlphaOne Sentiment. AlphaOne, a division of Accern, identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cutera earned a news impact score of 0.13 on AlphaOne’s scale. AlphaOne also assigned news coverage about the medical device company an impact score of 16 out of 100, meaning that recent media coverage is very unlikely to have an impact on the company’s share price in the near term.

These are some of the media stories that may have impacted AlphaOne’s rankings:

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

A number of analysts recently commented on the stock. Sidoti restated a “buy” rating and issued a $30.00 price objective (up previously from $27.00) on shares of Cutera in a research report on Saturday, June 3rd. Zacks Investment Research upgraded shares of Cutera from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective for the company in a research report on Thursday, February 16th. Finally, TheStreet cut shares of Cutera from a “b-” rating to a “c” rating in a research report on Monday, May 1st.

Cutera (NASDAQ:CUTR) traded up 1.74% during mid-day trading on Friday, hitting $23.35. 146,041 shares of the company were exchanged. The company has a market capitalization of $323.58 million, a P/E ratio of 89.46 and a beta of 0.62. Cutera has a 12-month low of $10.42 and a 12-month high of $24.78. The company’s 50-day moving average is $21.67 and its 200 day moving average is $19.80.

Cutera (NASDAQ:CUTR) last released its earnings results on Monday, May 1st. The medical device company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). Cutera had a return on equity of 9.21% and a net margin of 2.89%. The business had revenue of $29.30 million for the quarter, compared to the consensus estimate of $29 million. During the same period last year, the business earned ($0.16) earnings per share. The firm’s revenue for the quarter was up 30.8% compared to the same quarter last year. Analysts expect that Cutera will post $0.47 EPS for the current year.

In related news, EVP Larry Laber sold 2,563 shares of Cutera stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $24.36, for a total transaction of $62,434.68. Following the sale, the executive vice president now directly owns 74,203 shares of the company’s stock, valued at $1,807,585.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Miguel Pardos sold 5,000 shares of Cutera stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $20.00, for a total value of $100,000.00. Following the sale, the executive vice president now directly owns 44,698 shares in the company, valued at $893,960. The disclosure for this sale can be found here. Over the last three months, insiders have sold 158,910 shares of company stock worth $3,324,504. 11.60% of the stock is owned by company insiders.

WARNING: This news story was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.themarketsdaily.com/2017/06/17/somewhat-favorable-press-coverage-very-unlikely-to-affect-cutera-cutr-share-price.html.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply